Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1ad69b3c4596147f07f0a19af6e57d47 |
classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L2400-06 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-52 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61L27-26 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-36 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0019 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-0024 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-728 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P19-02 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-728 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-00 |
filingDate |
2015-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2016-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bdcc8735aaf4f6b5de99ba8baa52c85d http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_95de6dd314762d8e5ad4473f897162fc http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_fbced4d831835d568bf66c7c331d261e |
publicationDate |
2016-07-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
KR-101637883-B1 |
titleOfInvention |
Polyethylene glycol hydrogel injection |
abstract |
TECHNICAL FIELD The present invention relates to a poly (ethylene glycol) hydrogel injecting agent, and more particularly, to a buffer solution (first buffer solution) having a pH of 3.5 to 6 containing a polyethylene glycol derivative having an electrophilic reactive group; And a polyethylene glycol derivative having a nucleophilic reactor and a buffer solution (second buffer) having a pH of 7.5 to 11 containing hyaluronic acid are separately formed to improve the symptoms of arthritic diseases. The injectable preparation of the present invention is excellent in biocompatibility and can be administered for a long time in the joints to exhibit analgesic effect, cartilage protection and inflammation-inhibiting effect, thus preventing or treating effective arthritis. |
priorityDate |
2015-09-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |